Latest News & Features
Big Pharma
Massachusetts-based pharmaceutical company Akebia has had five Fibrogen patents for an anaemia treatment invalidated at the English High Court. 23 April 2020
Americas
NASCAR driver Caesar Bacarella’s sports clothing line and supplement business have been hit with a lawsuit by an Australia company. 23 April 2020
Medtech
The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis. 23 April 2020
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision which found that Banner Life Sciences wasn’t infringing a Biogen patent with its bioequivalent version of a multiple sclerosis drug. 23 April 2020
Big Pharma
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO. 22 April 2020
Big Pharma
Pressure is building on IP owners to offer up access to technology that could help fight COVID-19. Rory O'Neill looks at some of the implications for the patent system. 21 April 2020
Americas
A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment. 21 April 2020
Big Pharma
New legislation has been enacted to help in the efforts to deal with the COVID-19 outbreak, as Daphne Lainson and Nancy Pei of Smart & Biggar report. 21 April 2020
Americas
The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry. 20 April 2020
Medtech
The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices. 16 April 2020